Menu
Recruiting NCT04103281

Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis

Observational Sepsis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Sepsis.
Who it may be relevant to
Registry conditions: Sepsis. Basic parameters: 2 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

In this research study we want to learn more about the characteristics of neutrophils that are present in the blood and secretions from a breathing tube of patients with sepsis. Sepsis is a severe type of infection, affecting various parts of the body. Neutrophils are a type of white blood cell that are part of the body's immune system. Even though neutrophils are important in getting rid of germs, they also may be harmful to parts of the body by causing injury in the lungs in patients with sepsis. Neutrophils can change their character in sepsis. Because of this, it is important for doctors to know what kind of neutrophils are in the blood and secretions from the breathing tube of patients with sepsis so that they can work to develop therapies to prevent these cells from being harmful.

Interventions

  • Other Sepsis
    Sepsis patients in the ICU with a breathing tube

Primary outcome measures

  • Neutrophil characteristics [Time frame: One day]

Eligibility criteria

Case Inclusion Criteria:

  • sepsis patient in the ICU with a breathing tube

Control Inclusion Criteria:

  • scheduled for an elective surgical procedure and need preoperative blood draw or will have an intravenous catheter placed for the purpose of their surgical procedure
  • Plan to have endotracheal tube for planned procedures.

Exclusion criteria

  • On chronic immunosuppressive drugs such as chronic corticosteroid use, or preexisting immunodeficiency diseases (oncology patients, patients with transplantation)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Boston Children's Hospital — Boston

Identifiers

NCT: NCT04103281 · IRB-P00033027

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗